fda warning letters glp-1 compounding october 2025 is moving to restrict mass-marketed compounded products that aren't FDA-approved, companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified CDER Warning Letters Jump 50%
Description
Your Partner in Long-Term Wellness Whether you're transitioning off prescription GLP-1 medications, or simply looking for a natural appetite modulator, this formula is designed to help sustain balanced eating patterns and metabolic resilience

Digestion: 10 Billion CFU of clinically studied probiotics

Clinically Backed Prebiotic Fiber formulated to double GLP-1 levels, curb cravings, and promote regularity.
and with patients who have taken GLP-1 drugs and experienced widely varying reactions.
